Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Machine learning-based approach reveals essential features for simplified TSPO PET quantification in ischemic stroke patients.
Zatcepin A, Kopczak A, Holzgreve A, Hein S, Schindler A, Duering M, Kaiser L, Lindner S, Schidlowski M, Bartenstein P, Albert N, Brendel M, Ziegler SI. Zatcepin A, et al. Among authors: bartenstein p. Z Med Phys. 2023 Jan 20:S0939-3889(22)00128-3. doi: 10.1016/j.zemedi.2022.11.008. Online ahead of print. Z Med Phys. 2023. PMID: 36682921 Free article.
Evaluation of the Efficacy of a Combined Treatment Using the mTOR-Inhibitor Everolimus and [177Lu]Lu-DOTA-TATE in Nude CD1 Mice with SSTR-Expressing Pancreatic AR42J Xenograft Tumors.
Zellmer J, Yen HY, Kaiser L, Gildehaus FJ, Böning G, Steiger K, Hacker M, Bartenstein P, Todica A, Haug AR, Ilhan H. Zellmer J, et al. Among authors: bartenstein p. Biomedicines. 2022 Dec 1;10(12):3102. doi: 10.3390/biomedicines10123102. Biomedicines. 2022. PMID: 36551858 Free PMC article.
Toward Single-Time-Point Image-Based Dosimetry of 177Lu-PSMA-617 Therapy.
Brosch-Lenz J, Delker A, Völter F, Unterrainer LM, Kaiser L, Bartenstein P, Ziegler S, Rahmim A, Uribe C, Böning G. Brosch-Lenz J, et al. Among authors: bartenstein p. J Nucl Med. 2023 May;64(5):767-774. doi: 10.2967/jnumed.122.264594. Epub 2023 Jan 19. J Nucl Med. 2023. PMID: 36657980 Free PMC article.
Feasibility of radiomic feature harmonization for pooling of [18F]FET or [18F]GE-180 PET images of gliomas.
Zounek AJ, Albert NL, Holzgreve A, Unterrainer M, Brosch-Lenz J, Lindner S, Bollenbacher A, Boening G, Rupprecht R, Brendel M, von Baumgarten L, Tonn JC, Bartenstein P, Ziegler S, Kaiser L. Zounek AJ, et al. Among authors: bartenstein p. Z Med Phys. 2023 Feb;33(1):91-102. doi: 10.1016/j.zemedi.2022.12.005. Epub 2023 Jan 27. Z Med Phys. 2023. PMID: 36710156 Free PMC article.
Investigation of image-based lesion and kidney dosimetry protocols for 177Lu-PSMA-I&T therapy with and without a late SPECT/CT acquisition.
Resch S, Takayama Fouladgar S, Zacherl M, Sheikh GT, Liubchenko G, Rumiantcev M, Unterrainer LM, Wenter V, Bartenstein P, Ziegler SI, Ilhan H, Beyer L, Böning G, Delker A. Resch S, et al. Among authors: bartenstein p. EJNMMI Phys. 2023 Feb 9;10(1):11. doi: 10.1186/s40658-023-00529-8. EJNMMI Phys. 2023. PMID: 36757516 Free PMC article.
High-Grade Glioma Radiation Therapy and Reirradiation Treatment Planning Using Translocator Protein Positron Emission Tomography With 18F-GE-180.
Fleischmann DF, Büttner M, Unterrainer M, Corradini S, Zollner B, Hofmaier J, Bodensohn R, Thon N, Belka C, Bartenstein P, Albert NL, Niyazi M. Fleischmann DF, et al. Among authors: bartenstein p. Adv Radiat Oncol. 2023 Jan 26;8(3):101185. doi: 10.1016/j.adro.2023.101185. eCollection 2023 May-Jun. Adv Radiat Oncol. 2023. PMID: 36896209 Free PMC article.
Metabolic patterns on [18F]FDG PET/CT in patients with unresectable stage III NSCLC undergoing chemoradiotherapy ± durvalumab maintenance treatment.
Holzgreve A, Taugner J, Käsmann L, Müller P, Tufman A, Reinmuth N, Li M, Winkelmann M, Unterrainer LM, Nieto AE, Bartenstein P, Kunz WG, Ricke J, Belka C, Eze C, Unterrainer M, Manapov F. Holzgreve A, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2023 Jul;50(8):2466-2476. doi: 10.1007/s00259-023-06192-6. Epub 2023 Mar 23. Eur J Nucl Med Mol Imaging. 2023. PMID: 36951991 Free PMC article.
Is PSMA PET/CT cost-effective for the primary staging in prostate cancer? First results for European countries and the USA based on the proPSMA trial.
Holzgreve A, Unterrainer M, Calais J, Adams T, Oprea-Lager DE, Goffin K, Lopci E, Unterrainer LM, Kramer KKM, Schmidt-Hegemann NS, Casuscelli J, Stief CG, Ricke J, Bartenstein P, Kunz WG, Mehrens D. Holzgreve A, et al. Among authors: bartenstein p. Eur J Nucl Med Mol Imaging. 2023 Oct;50(12):3750-3754. doi: 10.1007/s00259-023-06332-y. Epub 2023 Jul 10. Eur J Nucl Med Mol Imaging. 2023. PMID: 37428216 Free PMC article.
Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies.
Finze A, Biechele G, Rauchmann BS, Franzmeier N, Palleis C, Katzdobler S, Weidinger E, Guersel S, Schuster S, Harris S, Schmitt J, Beyer L, Gnörich J, Lindner S, Albert NL, Wetzel CH, Rupprecht R, Rominger A, Danek A, Burow L, Kurz C, Tato M, Utecht J, Papazov B, Zaganjori M, Trappmann LK, Goldhardt O, Grimmer T, Haeckert J, Janowitz D, Buerger K, Keeser D, Stoecklein S, Dietrich O, Morenas-Rodriguez E, Barthel H, Sabri O, Bartenstein P, Simons M, Haass C, Höglinger GU, Levin J, Perneczky R, Brendel M. Finze A, et al. Among authors: bartenstein p. Mol Psychiatry. 2023 Oct;28(10):4438-4450. doi: 10.1038/s41380-023-02188-8. Epub 2023 Jul 26. Mol Psychiatry. 2023. PMID: 37495886 Free PMC article.
705 results